Market Place
Sourcing Support
All News #Library
Generics
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
11 Sep 2025 //
GLOBENEWSWIRE
Girard Sharp and Motley Rice Announce Proposed Settlement
27 May 2025 //
PR NEWSWIRE
Hikma Pharma to pay $50 million in narcolepsy drug antitrust case
08 May 2025 //
REUTERS
Jazz Pharma to pay $145 M to settle narcolepsy drug antitrust case
09 Apr 2025 //
REUTERS
Jazz sues generics for infringement on cannabis-derived drug
06 Jan 2023 //
FIERCE PHARMA
Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals
10 Dec 2018 //
PATENT LITIGATION
J&J unit to pay $360 million to U.S. to resolve charity kickback probe
07 Dec 2018 //
REUTERS
AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical
31 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
02 Oct 2018 //
PATENT LITIGATION
U.S. court denies Jazz Pharma bid to revive patents on narcolepsy drug
13 Jul 2018 //
REUTERS
Xyrem®(Sodium Oxybate): Jazz Pharmaceuticals v. Lupin
24 Apr 2018 //
PATENT LITIGATION
Xyrem®( Sodium Oxybate): Jazz Pharmaceuticals V. Mallinckrodt
03 Jan 2018 //
PATENT LITIGATION
Xyrem® (Sodium Oxybate): Jazz Pharmaceuticals V. Ascent Pharmaceuticals, Inc.
27 Jul 2017 //
PATENT LITIGATION
Xyrem (Sodium Oxybate): Jazz Pharmaceuticals v. Amneal Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
FDA approves generic version of Jazz Pharma`s sleep disorder drug
19 Jan 2017 //
REUTERS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.